Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000081699 | SCV000312313 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV001844032 | SCV000477812 | benign | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000278002 | SCV000477813 | benign | Amyotrophic Lateral Sclerosis, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001596953 | SCV001830296 | benign | not provided | 2021-05-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002055211 | SCV002421960 | benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001844032 | SCV003931299 | benign | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003233104 | SCV003931301 | benign | Amyotrophic lateral sclerosis type 4 | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000081699 | SCV000113630 | benign | not specified | 2012-08-14 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000081699 | SCV001744057 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000081699 | SCV001807198 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000081699 | SCV001968276 | benign | not specified | no assertion criteria provided | clinical testing |